• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症可能预测头颈癌患者的复发情况。

Sarcopenia may predict recurrence in patients with head and neck cancer.

作者信息

Colback Angela A, Arkfeld Daniel V, Paydar Alireza, Raslan Osama, Cates Daniel J, Abouyared Marianne

机构信息

Department of Otolaryngology - Head and Neck Surgery, University of California, Davis, Sacramento, California, USA.

Division of Neuroradiology, Department of Radiology, University of California Davis Medical Center, Sacramento, California, USA.

出版信息

Head Neck. 2025 Jan;47(1):282-288. doi: 10.1002/hed.27903. Epub 2024 Aug 13.

DOI:10.1002/hed.27903
PMID:39138607
Abstract

BACKGROUND

Malnutrition is a major consequence of head and neck cancer (HNC), often leading to decreased skeletal muscle mass and impacting survival. The goal of this study is to determine the effect of sarcopenia, as defined by skeletal muscle index (SMI), on survival in patients with HNC.

METHODS

This is a retrospective review of patients with HNC treated with surgery and/or radiation at a single tertiary care institute. All had pre-treatment imaging available for skeletal muscle index (SMI) measurements, and SMI was calculated at the level of the 3rd cervical vertebra. Sarcopenia was defined as an SMI < 41 cm/m in females and as <43 cm/m in underweight or healthy weight males. Sarcopenia was defined as <53 cm/m in overweight or obese males. Chi-square analysis was performed to compare recurrence and survival rates, and survival analysis was performed via Kaplan-Meir curve.

RESULTS

Hundred and twelve patients with HNC were evaluated, 84 men and 28 women with an average age of 60.9 years. Tumors were primarily located in the oral cavity (24.1%) and oropharynx (42%). The majority (69.6%) underwent surgery. Mean body mass index prior to treatment was 28. Sixty-nine patients (61.6%) in our cohort had low SMI. Mean follow-up was 3.9 ± 2.2 years. Recurrence rate was 26% in those with low SMI versus 2% in those without. Patients with low SMI were more likely to have a recurrence (p = 0.02). Overall survival was 72.5% in those with low SMI and 81% in those with normal SMI (p = 0.09).

CONCLUSIONS

Defining sarcopenia as a low skeletal muscle index at the third cervical vertebra is clinically relevant. This study demonstrates that low SMI at this level, and thus sarcopenia, was strongly associated with higher rates of recurrence.

摘要

背景

营养不良是头颈癌(HNC)的主要后果,常导致骨骼肌质量下降并影响生存。本研究的目的是确定由骨骼肌指数(SMI)定义的肌肉减少症对HNC患者生存的影响。

方法

这是一项对在单一三级医疗机构接受手术和/或放疗的HNC患者的回顾性研究。所有患者术前均有可用于测量骨骼肌指数(SMI)的影像资料,并在第三颈椎水平计算SMI。肌肉减少症定义为女性SMI < 41 cm/m,体重过轻或正常体重男性SMI < 43 cm/m。超重或肥胖男性的肌肉减少症定义为SMI < 53 cm/m。采用卡方分析比较复发率和生存率,并通过Kaplan-Meir曲线进行生存分析。

结果

共评估了112例HNC患者,其中84例男性和28例女性,平均年龄60.9岁。肿瘤主要位于口腔(24.1%)和口咽(42%)。大多数患者(69.6%)接受了手术。治疗前平均体重指数为28。队列中的69例患者(61.6%)SMI较低。平均随访时间为3.9 ± 2.2年。SMI低的患者复发率为26%,而SMI正常的患者复发率为2%。SMI低的患者更易复发(p = 0.02)。SMI低的患者总生存率为72.5%,SMI正常的患者为81%(p = 0.09)。

结论

将第三颈椎水平的低骨骼肌指数定义为肌肉减少症具有临床相关性。本研究表明,该水平的低SMI,即肌肉减少症,与较高的复发率密切相关。

相似文献

1
Sarcopenia may predict recurrence in patients with head and neck cancer.肌肉减少症可能预测头颈癌患者的复发情况。
Head Neck. 2025 Jan;47(1):282-288. doi: 10.1002/hed.27903. Epub 2024 Aug 13.
2
CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.CT 测量的骨骼肌量用于评估头颈部癌症患者的虚弱程度。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1060-1069. doi: 10.1002/jcsm.12443. Epub 2019 May 27.
3
Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.咀嚼肌指数用于指示头颈部癌症患者的骨骼肌量。
PLoS One. 2021 May 10;16(5):e0251455. doi: 10.1371/journal.pone.0251455. eCollection 2021.
4
Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.胸部骨骼肌指数对 CT 定义的头颈部癌症患者肌肉减少症评估有效。
Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5583-5594. doi: 10.1007/s00405-023-08162-y. Epub 2023 Aug 12.
5
The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.骨骼肌消耗对头颈部鳞状细胞癌的影响
ORL J Otorhinolaryngol Relat Spec. 2018;80(1):1-9. doi: 10.1159/000485515. Epub 2018 Jan 26.
6
Quantifying the severity of sarcopenia in patients with cancer of the head and neck.量化头颈部癌症患者的肌肉减少症严重程度。
Clin Nutr. 2024 Apr;43(4):989-1000. doi: 10.1016/j.clnu.2024.02.020. Epub 2024 Feb 22.
7
Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.头颈部癌症患者的营养状况和骨骼肌状况:对结局的影响。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2187-2198. doi: 10.1002/jcsm.12829. Epub 2021 Oct 21.
8
Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.低骨骼肌指数对肝癌肝切除术后预后的不良影响。
Int J Surg. 2016 Jun;30:136-42. doi: 10.1016/j.ijsu.2016.04.049. Epub 2016 May 4.
9
Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically.低骨骼肌质量对非手术治疗的头颈癌患者预后的影响
ORL J Otorhinolaryngol Relat Spec. 2023;85(1):36-43. doi: 10.1159/000527307. Epub 2022 Nov 24.
10
The validation of low-dose CT scans from the [F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans.用 [F]-FDG PET-CT 扫描的低剂量 CT 扫描来验证与诊断性颈部 CT 扫描相比评估骨骼肌量。
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1735-1742. doi: 10.1007/s00259-023-06117-3. Epub 2023 Feb 13.